Viridian Therapeutics, Inc.
Developing advanced medical treatments
- B2B
About Viridian Therapeutics, Inc.
A biotechnology company in Waltham, Massachusetts developing new treatments, including anti-IGF-1R monoclonal antibody for thyroid eye disease
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- Waltham, Massachusetts, United States
- Founded
- 2007
- Revenue
- $70.8MFY2025, publicly reported
- Website
- viridiantherapeutics.com
- linkedin.com/company/viridiantx
Viridian Therapeutics, Inc. at a glance
Viridian Therapeutics, Inc. is a B2B company in the Biotechnology Research industry, headquartered in Waltham, Massachusetts, United States.
Viridian Therapeutics, Inc. was founded in 2007.
Viridian Therapeutics, Inc. has 251–1,000 employees.
Viridian Therapeutics, Inc.'s revenue is $70.8M (FY2025, publicly reported).
Frequently asked questions about Viridian Therapeutics, Inc.
What is Viridian Therapeutics, Inc.'s revenue?
Viridian Therapeutics, Inc.'s revenue is $70.8M (FY2025, publicly reported).
How many employees does Viridian Therapeutics, Inc. have?
Viridian Therapeutics, Inc. has 251–1,000 employees.
Where is Viridian Therapeutics, Inc. headquartered?
Viridian Therapeutics, Inc. is headquartered in Waltham, Massachusetts, United States.
Selling to companies like Viridian Therapeutics, Inc.?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies